21 January 2019

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

21 January 2019 | n=37

  1. Stopard IJ, Mcgillen JB, Hauck K, Hallett TB, et al.
    The influence of constraints on the efficient allocation of resources for HIV prevention: a modelling study.
    AIDS 2019.

  2. Webel AR, Jenkins T, Vest M, Oliveria VHF, et al.
    Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults.
    AIDS 2019.

  3. Ling L, Wu T, To KKW, Cheung KW, et al.
    Vedolizumab-mediated integrin alpha4beta7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice.
    AIDS 2019.

  4. Sessa L, Reddel S, Manno E, Quagliariello A, et al.
    Distinct gut microbiota profile in ART-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
    AIDS 2019.

  5. Hua S, Scott JM, Hanna DB, Haberlen SA, et al.
    Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection.
    AIDS 2019.

  6. Ashare RL, Thompson M, Leone F, Metzger D, et al.
    Differences in the rate of nicotine metabolism among smokers with and without HIV.
    AIDS 2019.

  7. Phillips NJ, Thomas KGF, Myer L, Sacktor N, et al.
    Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: y-IHDS validation.
    AIDS 2019.

  8. Tate JP, Sterne JAC, Justice AC.
    Improved discrimination of mortality with Veterans Aging Cohort Study (VACS) Index 2.0 in HIV-positive individuals.
    AIDS 2019.

  9. Chaisson LH, Semitala FC, Asege L, Mwebe S, et al.
    Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    AIDS 2019.

  10. Dirajlal-Fargo S, Mussi-Pinhata MM, Weinberg A, Yu Q, et al.
    HIV-exposed uninfected infants have increased inflammation and monocyte activation.
    AIDS 2019.

  11. Lupo J, Germi R, Lancar R, Algarte-Genin M, et al.
    Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era.
    AIDS 2019.

  12. Maurice JB, Garvey L, Tsochatzis EA, Wiltshire M, et al.
    Monocyte-Macrophage activation is associated with NAFLD and liver fibrosis in HIV mono-infection independently of the gut microbiome and bacterial translocation.
    AIDS 2019.

  13. Hoots BE, Wejnert C, Martin A, Haaland R, et al.
    Undisclosed HIV infection among men who have sex with men in National HIV Behavioral Surveillance, 2014.
    AIDS 2019.

  14. Cook RR, Fulcher JA, Tobin NH, Li F, et al.
    Effects of HIV viremia on the gastrointestinal microbiome of young men who have sex with men.
    AIDS 2019.

  15. Spinelli MA, Glidden DV, Rodrigues WC, Wang G, et al.
    Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a PrEP demonstration project.
    AIDS 2018.

  16. Newsum AM, Kooij KW, Boyd A, Smit C, et al.
    Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM.
    AIDS 2019.

  17. Brittain K, Phillips TK, Zerbe A, Abrams EJ, et al.
    Long-term effects of unintended pregnancy on antiretroviral therapy outcomes among South African women living with HIV.
    AIDS 2019.

  18. Kim BH, Kelschenbach J, Borjabad A, Hadas E, et al.
    Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HAND in EcoHIV-infected mice.
    AIDS 2019.

  19. Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, et al.
    Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up.
    AIDS 2019.

  20. Kobe JB, Talbot O, Chen I, Eshleman SH, et al.
    Viral genetic linkage analysis among Black men who have sex with men (HIV Prevention Trials Network 061).
    AIDS Res Hum Retroviruses 2019.

  21. McKinnon LR, Achilles S, Bradshaw CS, Burgener A, et al.
    The evolving facets of bacterial vaginosis: implications for HIV transmission.
    AIDS Res Hum Retroviruses 2019.

  22. Swanstrom AE, Jacques A, Del Prete G, Bieniasz P, et al.
    Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV (stHIV) in Non-Human Primate Models of AIDS.
    AIDS Res Hum Retroviruses 2019.

  23. Bhukar R, Sachdeva RK, Suri D, Shandilya J, et al.
    Reduced NK Cell subsets in perinatally acquired long term non progressors HIV infected children.
    AIDS Res Hum Retroviruses 2019.

  24. Patel AS, Goparaju L, Sales JM, Mehta CC, et al.
    PrEP Eligibility among At-Risk Women in the Southern US: Associated Factors, Awareness and Acceptability.
    J Acquir Immune Defic Syndr 2019.

  25. Sakabumi DZ, Moore RC, Tang B, Delaney PA, et al.
    Chronic Distal Sensory Polyneuropathy is a Major Contributor to Balance Disturbances in Persons Living with HIV.
    J Acquir Immune Defic Syndr 2019.

  26. Maheu-Giroux M, Diabate S, Boily MC, Jean-Paul N, et al.
    Cost-Effectiveness of Accelerated HIV Response Scenarios in Cote d'Ivoire.
    J Acquir Immune Defic Syndr 2019.

  27. Katz DA, Dombrowski JC, Barry M, Spellman D, et al.
    STD Partner Services to Monitor and Promote HIV Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr 2019.

  28. Akilimali NA, Muema DM, Specht C, Chang CC, et al.
    Cryptococcosis-associated Immune Reconstitution Inflammatory Syndrome is associated with Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T-cells and Monocyte Activation.
    J Acquir Immune Defic Syndr 2019.

  29. Radwan D, Cachay E, Falade-Nwulia O, Moore RD, et al.
    HCV Screening and Treatment Uptake among Patients in HIV care During 2014-2015.
    J Acquir Immune Defic Syndr 2019.

  30. Sherman SG, Park JN, Galai N, Allen ST, et al.
    Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore city: Results from the SAPPHIRE study.
    J Acquir Immune Defic Syndr 2019.

  31. Venter WDF, Kambugu A, Chersich MF, Becker S, et al.
    Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial.
    J Acquir Immune Defic Syndr 2019;80:224-233.

  32. Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, et al.
    Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.
    J Acquir Immune Defic Syndr 2019;80:160-165.

  33. Gogia S, Zanni MV.
    Authors' Reply to Comments on "Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study".
    J Acquir Immune Defic Syndr 2019.

  34. Baumann A, Musaazi J, Kambugu A, Kalin M, et al.
    Virological outcome of patients with HIV drug resistance attending an urban out-patient clinic in Uganda: a need for structured adherence counselling and third line treatment options.
    J Acquir Immune Defic Syndr 2019.

  35. Minnis AM, Browne EN, Boeri M, Agot K, et al.
    Young women's stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa.
    J Acquir Immune Defic Syndr 2019.

  36. Mathur R, Hui Q, Huang Y, Gwinn M, et al.
    DNA Methylation Markers of Type 2 Diabetes among HIV-Positive and -Negative Male Veterans.
    J Infect Dis 2019.

  37. Louis FJ, Segaren N, Desinor O, Beard RS, et al.
    High Levels of HIV-1 Drug Resistance in Children Who Acquired HIV Infection Through Mother to Child Transmission in the Era of Option B+, Haiti, 2013-2014.
    Pediatr Infect Dis J 2018.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

19 August 2019

12 August 2019

05 August 2019

29 July 2019

22 July 2019

21 January 2019

Multidisciplinary Journal Club

  1. Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, et al.
    Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.
    J Clin Oncol. 2019 Jan 8:JCO1800149. doi: 10.1200/JCO.18.00149.

  2. Ansell SM, Minnema MC, Johnson P, Timmerman JM, et al.
    Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
    J Clin Oncol. 2019 Jan 8:JCO1800766. doi: 10.1200/JCO.18.00766.

  3. Mahmud N, Kaplan DE, Taddei TH, Goldberg DS, et al.
    Incidence and Mortality of Acute on Chronic Liver Failure using Two Definitions in Patients with Compensated Cirrhosis.
    Hepatology. 2019 Jan 7. doi: 10.1002/hep.30494.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016